Study protocol: multicenter double-blind, randomized, placebo-controlled trial of rituximab for the treatment of childhood-onset early-stage uncomplicated frequently relapsing or steroid-dependent nephrotic syndrome (JSKDC10 trial)

Ítems similars

• Rituximab in steroid-sensitive nephrotic syndrome: lessons from clinical trials
  per: Iijima, Kazumoto, et al.
  Publicat: (2017)
• Study protocol: mycophenolate mofetil as maintenance therapy after rituximab treatment for childhood-onset, complicated, frequently-relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicenter double-blind, randomized, placebo-controlled trial (JSKDC07)
  per: Horinouchi, Tomoko, et al.
  Publicat: (2018)
• Rituximab for nephrotic syndrome in children
  per: Iijima, Kazumoto, et al.
  Publicat: (2016)
• Rituximab Treatment for Nephrotic Syndrome in Children
  per: Iijima, Kazumoto, et al.
  Publicat: (2014)
• Study protocol: high-dose mizoribine with prednisolone therapy in short-term relapsing steroid-sensitive nephrotic syndrome to prevent frequent relapse (JSKDC05 trial)
  per: Hama, Taketsugu, et al.
  Publicat: (2018)